Seamus Mulligan

CIK: 0001536639

Transaction Breakdown

Open Market Buys (P)4 (57.1%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (14.3%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

JAZZ

Jazz Pharmaceuticals plc

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

JAZZ
Jazz Pharmaceuticals plc
Aug 5, 2026
Award(A)
Direct
1.6K shares-
JAZZ
Jazz Pharmaceuticals plc
May 28, 2026
Exercise(M)
Direct
3.4K shares at avg. $138.08$472K
JAZZ
Jazz Pharmaceuticals plc
Aug 7, 2025
Award(A)
Direct
3.5K shares-
JAZZ
Jazz Pharmaceuticals plc
May 12, 2025
Purchase(P)
Indirect
1.6K shares at avg. $103.00$167K
JAZZ
Jazz Pharmaceuticals plc
May 9, 2025
Purchase(P)
Indirect
100 shares at avg. $99.71$10K
JAZZ
Jazz Pharmaceuticals plc
May 9, 2025
Purchase(P)
Indirect
80.7K shares at avg. $98.10$7.9M
JAZZ
Jazz Pharmaceuticals plc
May 9, 2025
Purchase(P)
Indirect
19.2K shares at avg. $98.91$1.9M

		Type	Shares	Price		Ownership
Aug 5, 2026	JAZZ Jazz Pharmaceuticals plc	Award(A)	1,605	-	$0	Direct
May 28, 2026	JAZZ Jazz Pharmaceuticals plc	Exercise(M)	3,415	$138.08	$471,543	Direct
Aug 7, 2025	JAZZ Jazz Pharmaceuticals plc	Award(A)	3,507	-	-	Direct
May 12, 2025	JAZZ Jazz Pharmaceuticals plc	Purchase(P)	1,621	$103.00	$166,962	Indirect
May 9, 2025	JAZZ Jazz Pharmaceuticals plc	Purchase(P)	100	$99.71	$9,971	Indirect
May 9, 2025	JAZZ Jazz Pharmaceuticals plc	Purchase(P)	80,684	$98.10	$7,915,472	Indirect
May 9, 2025	JAZZ Jazz Pharmaceuticals plc	Purchase(P)	19,216	$98.91	$1,900,678	Indirect

1-7 of 7 transactions

About Mulligan Seamus

Mulligan Seamus (SEC CIK 0001536639) files insider reports with the SEC as Director of Jazz Pharmaceuticals plc (JAZZ).

Signal8 holds 4 ownership filings by Mulligan Seamus, all Form 4s, filed between May 13, 2025 and Aug 7, 2026. Those filings report 7 transactions, from May 9, 2025 to Aug 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Mulligan Seamus's filings is in DUBLIN 4.

Recent filings by Mulligan Seamus

Aug 5, 2026: Grant or award of JAZZ shares (Form 4, code A).
May 28, 2026: Option exercise of JAZZ shares (Form 4, code M).
Aug 7, 2025: Grant or award of JAZZ shares (Form 4, code A).
May 12, 2025: Open-market purchase of JAZZ shares (Form 4, code P).
May 9, 2025: Open-market purchases of JAZZ shares (3 lines, Form 4, code P).

Other insiders filing for Jazz Pharmaceuticals plc (JAZZ)

GALA RENEE D, President & CEO
COZADD BRUCE C, Director
Patil Neena M, EVP & Chief Legal Officer
Henderson Mary Elizabeth, SVP, Technical Operations
Smith Mark Douglas, Director
RIEDEL NORBERT G, Director

How to read Form 4 transaction codes